Skip to main content
NewslettersWatchlist

Generation Bio Co.(GBIO-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low3.47
Day High3.82
Open:3.72
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
AllPennyStocks.com
Biotech Soars After Strategic Reorganization Announcement
Barchart
Stocks Set to Open Lower as Investors Await Key U.S. Inflation Data and Big Tech Earnings
Globe Newswire
Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results
Globe Newswire
Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference
Globe Newswire
Generation Bio Appoints Dannielle Appelhans to Its Board of Directors
Globe Newswire
Generation Bio to Present at the 2022 Jefferies Healthcare Conference
Globe Newswire
Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results
Globe Newswire
Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference
Globe Newswire
Generation Bio to Participate in 42nd Annual Cowen Health Care Conference
Globe Newswire
Generation Bio Outlines 2022 Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results
Globe Newswire
Generation Bio Promotes Antoinette Paone, M.S., MBA to Chief Operating Officer
Globe Newswire
Generation Bio to Present at 40th Annual J.P. Morgan Healthcare Conference
Business Wire
SHAREHOLDER ALERT: Robbins LLP Investigates Generation Bio Co. (GBIO) on Behalf of Shareholders
Globe Newswire
Generation Bio Provides Update on Preclinical Studies for Hemophilia A Program
Globe Newswire
Generation Bio Reports Business Highlights and Third Quarter 2021 Financial Results
Globe Newswire
Generation Bio Presents Data Demonstrating First Lipid Nanoparticle to Achieve Uniform Retinal Transduction and Tolerability via Sub-Retinal Delivery of ceDNA and mRNA at the European Society of Gene and Cell Therapy 2021 Annual Virtual Congress
Globe Newswire
Generation Bio to Present at Jefferies Virtual Gene Therapy/Editing Summit
Globe NewsWire
Generation Bio Reports Business Highlights and Second Quarter 2021 Financial Results
Globe NewsWire
Generation Bio to Present at Wedbush PacGrow Healthcare Conference 2021
Globe NewsWire
Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update
Globe NewsWire
Generation Bio to Present at William Blair Biotech Focus Conference
Globe NewsWire
Generation Bio to Present at the JMP Securities Life Sciences Conference
Globe NewsWire
Generation Bio to Present at the Jefferies Virtual Healthcare Conference
Globe NewsWire
OXURION NV Appoints Tom Graney, CFA as Chief Executive Officer
Globe NewsWire
Generation Bio Presents Preclinical Data Demonstrating Broad Potential of Gene Therapy Platform at ASGCT and Reports First Quarter Financial Results
Globe NewsWire
Generation Bio to Present at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting
Globe NewsWire
Generation Bio to Present at 20th Annual Needham Virtual Healthcare Conference
Globe NewsWire
Generation Bio Reports Fourth Quarter and Full Year 2020 Financial Results
Globe NewsWire
Oxurion NV Business and Financial Update – FY 2020
Globe NewsWire
Generation Bio Appoints Ron Cooper to Its Board of Directors
Globe NewsWire
Generation Bio Announces Closing of Public Offering
Globe NewsWire
Generation Bio Announces Pricing of Public Offering

Profile

Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.